Global Antipsychotic Medicine Market Research Report 2022
Report Code: KNJ1408844
Publisher: Date of Publish:
No. of Pages: 86 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
The global Antipsychotic Medicine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Antipsychotic Medicine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Antipsychotic Medicine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028. The global market for Antipsychotic Medicine in Hospital Pharmacy is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028. The major global companies of Antipsychotic Medicine include Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline and Otsuka Pharma, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue. Considering the economic change due to COVID-19, Oral Antipsychotics, which accounted for % of the global market of Antipsychotic Medicine in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028. Report Scope This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medicine. The Antipsychotic Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antipsychotic Medicine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Antipsychotic Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include: Johnson and Johnson Eli Lilly Bristol-Myers Squibb AstraZeneca Novartis Allergan Pfizer GlaxoSmithKline Otsuka Pharma Sumitomo Dainippon Alkermes Vanda Pharma Product Type Insights Global markets are presented by Antipsychotic Medicine type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Antipsychotic Medicine are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028). Antipsychotic Medicine segment by Type Oral Antipsychotics Injectable Antipsychotics Application Insights This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028). This report also outlines the market trends of each segment and consumer behaviors impacting the Antipsychotic Medicine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antipsychotic Medicine market. Antipsychotic Medicine Segment by Application Hospital Pharmacy Clinic Pharmacy Online Pharmacy Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Antipsychotic Medicine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipsychotic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Antipsychotic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This report stays updated with novel technology integration, features, and the latest developments in the market This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antipsychotic Medicine industry. This report helps stakeholders to gain insights into which regions to target globally This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipsychotic Medicine. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Core Chapters Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Antipsychotic Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue and gross margin, product introduction, recent development, etc. Chapter 12: The main points and conclusions of the report.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antipsychotic Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Oral Antipsychotics 1.2.3 Injectable Antipsychotics 1.3 Market by Application 1.3.1 Global Antipsychotic Medicine Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Clinic Pharmacy 1.3.4 Online Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antipsychotic Medicine Market Perspective (2017-2028) 2.2 Antipsychotic Medicine Growth Trends by Region 2.2.1 Antipsychotic Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Antipsychotic Medicine Historic Market Size by Region (2017-2022) 2.2.3 Antipsychotic Medicine Forecasted Market Size by Region (2023-2028) 2.3 Antipsychotic Medicine Market Dynamics 2.3.1 Antipsychotic Medicine Industry Trends 2.3.2 Antipsychotic Medicine Market Drivers 2.3.3 Antipsychotic Medicine Market Challenges 2.3.4 Antipsychotic Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antipsychotic Medicine Players by Revenue 3.1.1 Global Top Antipsychotic Medicine Players by Revenue (2017-2022) 3.1.2 Global Antipsychotic Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Antipsychotic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Antipsychotic Medicine Revenue 3.4 Global Antipsychotic Medicine Market Concentration Ratio 3.4.1 Global Antipsychotic Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Medicine Revenue in 2021 3.5 Antipsychotic Medicine Key Players Head office and Area Served 3.6 Key Players Antipsychotic Medicine Product Solution and Service 3.7 Date of Enter into Antipsychotic Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antipsychotic Medicine Breakdown Data by Type 4.1 Global Antipsychotic Medicine Historic Market Size by Type (2017-2022) 4.2 Global Antipsychotic Medicine Forecasted Market Size by Type (2023-2028) 5 Antipsychotic Medicine Breakdown Data by Application 5.1 Global Antipsychotic Medicine Historic Market Size by Application (2017-2022) 5.2 Global Antipsychotic Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Antipsychotic Medicine Market Size (2017-2028) 6.2 North America Antipsychotic Medicine Market Size by Country (2017-2022) 6.3 North America Antipsychotic Medicine Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Antipsychotic Medicine Market Size (2017-2028) 7.2 Europe Antipsychotic Medicine Market Size by Country (2017-2022) 7.3 Europe Antipsychotic Medicine Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Antipsychotic Medicine Market Size (2017-2028) 8.2 Asia-Pacific Antipsychotic Medicine Market Size by Country (2017-2022) 8.3 Asia-Pacific Antipsychotic Medicine Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Antipsychotic Medicine Market Size (2017-2028) 9.2 Latin America Antipsychotic Medicine Market Size by Country (2017-2022) 9.3 Latin America Antipsychotic Medicine Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antipsychotic Medicine Market Size (2017-2028) 10.2 Middle East & Africa Antipsychotic Medicine Market Size by Country (2017-2022) 10.3 Middle East & Africa Antipsychotic Medicine Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Johnson and Johnson 11.1.1 Johnson and Johnson Company Detail 11.1.2 Johnson and Johnson Business Overview 11.1.3 Johnson and Johnson Antipsychotic Medicine Introduction 11.1.4 Johnson and Johnson Revenue in Antipsychotic Medicine Business (2017-2022) 11.1.5 Johnson and Johnson Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Detail 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Antipsychotic Medicine Introduction 11.2.4 Eli Lilly Revenue in Antipsychotic Medicine Business (2017-2022) 11.2.5 Eli Lilly Recent Development 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Detail 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Introduction 11.3.4 Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2017-2022) 11.3.5 Bristol-Myers Squibb Recent Development 11.4 AstraZeneca 11.4.1 AstraZeneca Company Detail 11.4.2 AstraZeneca Business Overview 11.4.3 AstraZeneca Antipsychotic Medicine Introduction 11.4.4 AstraZeneca Revenue in Antipsychotic Medicine Business (2017-2022) 11.4.5 AstraZeneca Recent Development 11.5 Novartis 11.5.1 Novartis Company Detail 11.5.2 Novartis Business Overview 11.5.3 Novartis Antipsychotic Medicine Introduction 11.5.4 Novartis Revenue in Antipsychotic Medicine Business (2017-2022) 11.5.5 Novartis Recent Development 11.6 Allergan 11.6.1 Allergan Company Detail 11.6.2 Allergan Business Overview 11.6.3 Allergan Antipsychotic Medicine Introduction 11.6.4 Allergan Revenue in Antipsychotic Medicine Business (2017-2022) 11.6.5 Allergan Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Antipsychotic Medicine Introduction 11.7.4 Pfizer Revenue in Antipsychotic Medicine Business (2017-2022) 11.7.5 Pfizer Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Detail 11.8.2 GlaxoSmithKline Business Overview 11.8.3 GlaxoSmithKline Antipsychotic Medicine Introduction 11.8.4 GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2017-2022) 11.8.5 GlaxoSmithKline Recent Development 11.9 Otsuka Pharma 11.9.1 Otsuka Pharma Company Detail 11.9.2 Otsuka Pharma Business Overview 11.9.3 Otsuka Pharma Antipsychotic Medicine Introduction 11.9.4 Otsuka Pharma Revenue in Antipsychotic Medicine Business (2017-2022) 11.9.5 Otsuka Pharma Recent Development 11.10 Sumitomo Dainippon 11.10.1 Sumitomo Dainippon Company Detail 11.10.2 Sumitomo Dainippon Business Overview 11.10.3 Sumitomo Dainippon Antipsychotic Medicine Introduction 11.10.4 Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2017-2022) 11.10.5 Sumitomo Dainippon Recent Development 11.11 Alkermes 11.11.1 Alkermes Company Detail 11.11.2 Alkermes Business Overview 11.11.3 Alkermes Antipsychotic Medicine Introduction 11.11.4 Alkermes Revenue in Antipsychotic Medicine Business (2017-2022) 11.11.5 Alkermes Recent Development 11.12 Vanda Pharma 11.12.1 Vanda Pharma Company Detail 11.12.2 Vanda Pharma Business Overview 11.12.3 Vanda Pharma Antipsychotic Medicine Introduction 11.12.4 Vanda Pharma Revenue in Antipsychotic Medicine Business (2017-2022) 11.12.5 Vanda Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com